Meeting program
Saturday, November 4
*All times are in EET.
13:15 - 13:30 EET Opening remarks
13:30 - 14:30 EET Session 1: Immunotherapy in indolent lymphomas
Hall A
Chairs: O Meltem Akay (Türkiye) & A Ghadeer (Jordan)
- How to approach relapsed follicular lymphoma
M Ladetto (Italy) - Overview of mantle cell lymphoma
M Dreyling (Germany) - Panel discussion
All speakers
13:30 - 14:30 EET Session 2: Inherited red blood cell disorders
Hall B
Chair: H Apak (Türkiye)
- Iron overload in inherited red blood cell disorders (pathopysiological and clinical aspects)
D Girelli (Italy) - Hereditary hemolytic anemias: How to diagnose
N Roy (United Kingdom) - Panel discussion
All speakers
14:30 - 14:45 EET Coffee break
14:45 - 15:30 EET Satellite Symposium: BMS
Hall A
15:30 - 15:45 EET Coffee break
15:45 - 16:30 EET Session 3: Myeloid malignancies
Hall A
Chairs: L Kaynar (Türkiye), A Fadhil Alwan (Iraq) & R Ben Lakhal (Tunisia)
- Clonal hematopoiesis - Causes and consequences
K Grønbæk (Denmark) - Panel discussion
All speakers
15:45 - 16:30 EET Session 4: Pediatric hematology
Hall B
Chair: H Ören (Türkiye)
- Pediatric acute lymphoblastic leukemia (ALL)
A Vora (United Kingdom) - Panel discussion
All speaker
16:30 - 16:45 EET Coffee break
16:45 - 17:45 EET Session 5: Novel agents in multiple myeloma
Hall A
Chairs: V Huseynov (Azerbaijan) & WF Al Tameemi (Iraq)
- From trials to clinical practice: Novel immunotherapies in MM, focus on BCMA-directed drugs
S Manier (France) - Novel targets and drugs in multiple myeloma
D Coriu (Romania) - Panel discussion
All speakers
16:45 - 17:45 EET Session 6: Acute acquired thrombosis and hemostasis challenges
Hall B
Chairs: N Andıç (Türkiye) & S Mahjoub (Tunisia)
- Novel issues in hematological cancer patients
A Falanga (Italy) - Implications of liver disease to coagulation disorders
T Lisman (The Netherlands) - Panel discussion
All speaker
17:45 - 18:00 EET Coffee break
18:00- 19:15 EET Regional Joint Symposium: Access to medicine / diagnostics
Hall A
Chair: MC Ar (Türkiye) & M Dreyling (Germany)
- Turkish hemoglobinopathy registry results
S Aydin (Türkiye) - Thalassemia in Azerbaijan: Epidemiology, Prevention and Management
K Jafarova (Azerbaijan) - Value of retics hb for the diagnosis of ida
A Awidi (Jordan) - Myelodysplastic/Myeloproliferative neoplasms; clinical cases based minireview)
Z Akram Thabit (Iraq) - Access to lymphoma medicine and diagnostics
R Mansouri (Tunisia)
19:15 - 19:30 EET Closing remarks
Back